At a Glance
| Phenylpiracetam | Adrafinil | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 100–200 mg | 250–400 mg |
| Total Duration | 0.5–1 hrs | 6.3–9 hrs |
| Routes | oral | oral |
Phenylpiracetam, a Stimulants, Nootropic, and Adrafinil, a Stimulants, Nootropic, Eugeroics, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Phenylpiracetam is classified as a Stimulants, Nootropic while Adrafinil is a Stimulants, Nootropic, Eugeroics, meaning they approach altered states through different pharmacological mechanisms. They share 7 documented effects in common, with 22 effects unique to Phenylpiracetam and 2 unique to Adrafinil. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Phenylpiracetam | Adrafinil | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 100–200 mg | 250–400 mg |
| Total Duration | 0.5–1 hrs | 6.3–9 hrs |
| Routes | oral | oral |
| Effects | 29 documented | 9 documented |
| Interaction | Caution | |
| Level | Phenylpiracetam | Adrafinil |
|---|---|---|
| Threshold | 50 mg | 100 mg |
| Light | 50–100 mg | 150–250 mg |
| Common | 100–200 mg | 250–400 mg |
| Strong | 200–400 mg | 400–600 mg |
| Heavy | 400 mg | 600 mg |
Phenylpiracetam
Adrafinil
Increased cardiovascular strain and neurotoxicity risk